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1. Introduction 
The addition of physiological concentrations of 
insulin to an adipocyte subcellular system consisting 
of plasma membranes and mitochondria has been 
shown to rapidly dephosphorylate the a-subunit of 
the mitochondrial enzyme pyruvate dehydrogenase 
[1,2] and to increase nzyme activity [3,4]. This 
effect could be demonstrated only when plasma 
membranes were present [2] and could be mimicked 
by other insulin-like ligands [3]. These data suggested 
that an insulin-sensitive material was generated from 
the plasma membranes and that this material may 
represent the putative chemical mediator of insulin 
action. 
Subsequent work has shown that insulin treatment 
of intact adipocytes [5] and adipocyte plasma mem- 
branes [6,7] increased the amount or activity of a 
low M r (1000-1500), acid-stable material which 
stimulated pyruvate dehydrogenase in mitochondria 
from adipocytes. To substantiate hat this material 
represents he chemical mediator of insulin action, 
two criteria must be met: 
(i) The quantity of the material recovered from cells 
should differ according to the insulin sensitivity 
of these cells. Such differences have been found 
following extraction of the mediator from insulin- 
treated and control cells. The insulin4nsensitive 
cells used were IM9 lymphocytes [8] and the 
insulin-sensitive c lls studied include skeletal 
muscle in [9,10] and adipocytes and hepatoma 
cells in [5,11]. 
(ii) The mediator should modulate insulin-sensitive 
enzymes in a manner analogous to that induced 
by insulin treatment of whole cells. The mediator 
alters the activity of 3 insulin-sensitive enzymes, 
glycogen synthase [9], pyruvate dehydrogenase 
[3-7,10] and [Ca 2+ + MgZ+]ATPase [12]. 
This study expands the number of insulin-sensitive 
enzymes tested by measuring the effects of the medi- 
ator from adipocytes on the low K m and high K m 
cyclic AMP phosphodiesterase. 
2. Materials and methods 
Male Sprague-Dawley rats (120 g) were obtained 
from Harlan Industries (Madison Wl). Most chemicals 
including albumin (fraction V) and collagenase were 
purchased from Sigma; porcine insulin was a gift 
from Dr R. Chance of Eli Lilly; [1-14C]pyruvic acid 
and cyclic [2,8-3H]AMP were purchased from 
New England Nuclear; Norit charcoal and formic acid 
(90%) were purchased from Fisher; organic scintilla- 
tor solution was from Amersham. The lots of colla- 
genase and albumin used were chosen as in [3]. 
Isolated adipocytes and adipocyte plasma mem- 
branes, mitochondria and microsomes were prepared 
as in [13] except hat EDTA was omitted. The assay 
for pyruvate dehydrogenase and the method for 
extracting the chemical mediator from partially puri- 
fied plasma membranes [6] and from insulin-treated 
and untreated (control) adipocytes [5] has been 
detailed. The low and high K m cyclic AMP phospho- 
diesterase were assayed in the microsomal fraction as 
in [14]. The concentration of cyclic AMP used for 
the low K m assay was 0.1 mM and for the high K m 
assay, 250 mM; 0.1 ~Ci and 1.0 ~tCi of cyclic [3H] AMP 
was added per assay tube, respectively. 
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3. Results 
3.1. The effect of  the chemical mediator from intact 
adipocytes on low K m cyclic AMP phosphodies- 
terase 
Table 1 demonst rates  the effect of  4 Sephadex 
G-25 fract ions o f  extracts  f rom insul in-treated and 
cont ro l  adipocytes on low K m cyclic AMP phospho-  
diesterase. Fract ion III f rom the insul in-treated cells 
resulted in the greatest act ivat ion of  low K m cyclic 
AMP phosphodiesterase compared to the other  frac- 
t ions. The greatest di f ference between the insulin- 
t reated and contro l  cells was observed with f ract ion III. 
F ract ion III corresponds to M r ~ 1000-1500 as indi- 
cated by pept ide and nucleot ide markers.  The effect 
of  these same 4 fract ions on pyruvate dehydrogenase 
was determined (not  shown).  Again, only  fract ion III 
f rom the insul in-treated cells caused signif icantly 
greater enzyme activity compared to the same frac- 
t ion f rom contro l  cells. 
Fig.1 summarizes the dose- response  relat ionship 
for  3 o f  the Sephadex G-25 fract ions f rom insulin- 
t reated adipocytes on low K m cyclic AMP phosphodi -  
esterase. Increasing volumes of  2, 5, 10 and 20/21 of  
the active fract ion,  f ract ion III, f rom insul in-treated 
cells produced a progressive rise in enzyme activity 
above basal levels to a p lateau of  42 pmol .  mg -~ . 
rain -~ at 10/A. In each assay 10/~1 fract ion III were 
used unless specif ied otherwise. Varying the volume 
of  the f ract ions eluted before or after f ract ion l l I  
showed no  signif icant increase in enzyme activity 
above basal levels. 
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Fig.1. The effect of the quantity of 3 Sephadex G-25 frac- 
tions from insulin-treated a ipocytes on the activity of the 
low K m cyclic AMP phosphodiesterase. Theresults are from a 
single representative experiment performed in triplicate. The 
basal activity was 103.9 ~+ 1.2 pmol. mg -1 . min-L 
3.2. The effect of  the chemical mediator from 
adipoeyte plasma membranes on low K m cylic 
AMP phosphodiesterase 
Table 2 i l lustrates the effect of  Sephadex G-25 
fract ions of  supernatant  derived f rom adipocyte 
plasma membranes  on pyruvate dehydrogenase and 
low K m cyclic AMP phosphodiesterase.  Fract ion III 
caused the greatest act ivat ion of  both  pyruvate dehy- 
drogenase and low K m cychc AMP phosphodiesterase.  
Table 3 demonstrates  that  the active Sephadex G-25 
fract ion f rom the supernatant  f rom adipocyte plasma 
Table 1 
The effect of Sephadex G-25 fractions from insulin-treated 
and control adipocytes on low K m cyclic AMP 
phosphodiesterase 
Fraction Insulin- Control Change 
no. treated (pmol. mg -~ . min -~) 
Table 2 
The effect of Sephadex G-25 fractions of supernatant from 
adipocyte plasma membranes on pyruvate dehydrogenase 
and low K m cyclic AMP phosphodiesterase 
Fraction PDH act. Low K m PDE act. 
no. (nmol. mg -~ . min -~) (pmol. mg -~ . min -~) 
I 59.6±5.2 54£± 3.9 +5.1 
1I 52.3±2.9 51.2± 8.0 +1.1 
Ili 91.3±5.1 61.7±10.6 +29.6 
IV 71.4±2.6 66.7± 3.0 +4.7 
I 17 .4e l .8  95.1±1.6 
II 6 .5e l .0  83.8±3.1 
III 65 .1e l .7  117.0±3.3 
IV 32.3±3.5 101.3±2.6 
The results are from a single representative experiment done 
in triplicate, and the values represent the mean _+ SEM, The 
column labeled 'Change' represents he difference between the 
insuLin-treated group and the control. Of each fraction 10/~1 
were added. The basal activity was 55.1 _+ 4.8 pmol. mg -~ . 
min-~ and the activity in the presence of Sephadex G-25 
buffer was 59.9 -+ 5.9 pmol. mg -j . min -~ 
The results are from a single representative experiment per- 
formed in triplicate, with the values expressed as mean _+ SEM. 
Of each fraction 50 ~1 were added to the PDH assay. Tile 
activity in the presence of Sephadex G-25 buffer was 
10.2 _+ 1.5 nmol.  mg -1 . min -1. Of each fraction 10 ~1 were 
added to the low K m PDE assay. The activity in the presence 
of Sephadex G-25 buffer was 95.5 _+ 4.4 pmol. mg -~ • min -t  
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Table 3 
Dose-response of Sephadex G-25 fraction III from the 
supernatant ofadipocyte plasma membranes on low K m 
cyclic AMP phosphodiesterase ctivity 
Fraction 
vol. (~1) 
Enzyme activity above basal for fraction II1 
(pmol. mg- I  min-') 
2 0 
5 +14.8 
10 +25.9 
20 +21.8 
The results are from a single representative experiment per- 
formed in tripficate. The basal activity was 127.5 -+ 1.6 pmol. 
mg -1  " mj / ]  -1  
membranes, fraction III, possesses a dose-response 
relationship similar to that observed for the active 
Sephadex G-25 fraction of extracts from insulin- 
treated adipocytes. In both the experiments using 
whole cell extract or plasma membrane released medi- 
ator, the relative potency of the mediator was equiva- 
lent in the pyruvate dehydrogenase and the low K m 
cyclic AMP phosphodiesterase assays based on the 
volumes of  the active fractions required for maximal 
response that were added per unit volume of assay. 
cytes. This enzyme can be added to the list of insulin- 
sensitive nzymes whose activity is modulated by the 
chemical mediator further substantiating that this 
mediator functions as a second messenger for insulin 
action. 
The low K m cyclic AMP phosphodiesterase from 
liver plasma membranes i unique in that insulin, as 
well as epinephrine and glucagon, stimulate its activ- 
ity [14]. In addition the effect of glucagon and insulin 
are additive, suggesting separate mechanisms of acti- 
vation. In [15] insulin was reported to increase the 
phosphorylation f the enzyme from liver. If insulin 
activates the low K m cyclic AMP phosphodiesterase 
by increasing phosphorylation f the enzyme, then 
this mechanism would be opposite to that observed 
for other enzymes that are activated by insulin through 
dephosphorylation, such as glycogen synthase [9] 
and pyruvate dehydrogenase [3-7,10].  We are explor- 
ing the possibility that phosphorylation of the low 
K m cyclic AMP phosphodiesterase from adipocytes 
alters the activity of the enzyme. If the alteration of 
low K m phosphodiesterase by the chemical mediator 
is by covalent modification, then activation must 
involve dephosphorylation si ce no ATP was added in 
the assay. 
3.3. The effect of the chemical mediator from 
adipocytes and adipocyte plasma membrane on 
high K m cyclic AMP phosphodiesterase 
Fraction I l I  from insulin-treated adipocytes failed 
to significantly increase or decrease the activity of 
high K m cyclic AMP phosphodiesterase compared to 
control (764 +- 17.3 pmol .  mg -1 . rain -~ vs 782 + 
20.1 pmol .  mg -~ . min -1, respectively). A similar set 
of studies has been performed with the material 
obtained from adipocyte plasma membranes with 
results identical to those obtained when the extracts 
from intact adipocytes were assayed. 
4. Discussion 
This study has shown that a chemical mediator 
from insulin-treated adipocytes and adipocyte plasma 
membranes increased the activity of the low K m cyclic 
AMP phosphodiesterase in a dose-dependent manner, 
but had no effect on the high K m cyclic AMP phos- 
phodiesterase. These changes in enzyme activity par- 
allel the known effect of insulin on the low K m cyclic 
AMP phosphodiesterase ssayed from intact adipo- 
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